Fred Alger Management »

First Tracks Biotherapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.4M 218k 20.12

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Amazon.com Equity (AMZN)
Nebius Group N.V. Class A Equity (NBIS)
Alphabet Inc. Class C Equity (GOOG)
Apple Equity (AAPL)
Western Digital Corporation Equity (WDC)
Meta Platforms Inc Class A Equity (META)
Broadcom Equity (AVGO)
Space Exploration Technologies Corp. Class A Equity (SPCX)
Tesla Equity (TSLA)
AppLovin Corp. Class A Equity (APP)
Astera Labs Equity (ALAB)
Talen Energy Corp Equity (TLN)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics